NeoGenomics (NEO) Tops Q1 EPS by 2c, reaffirms outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to NeoGenomics (NEO) Tops Q1 EPS by 2c, reaffirms outlook

Neogenomics (NEO) PT Lowered to $21 at BTIG

May 2, 2024 5:24 AM EDT

BTIG analyst Mark Massaro lowered the price target on Neogenomics (NASDAQ: NEO) to $21.00 (from $23.00) while maintaining a Buy rating.

The analyst comments "In this note, we update our NEO model following the company's Q1 call. NEO delivered a good 4% beat on the top line, delivered another quarter of positive Adj. EBITDA, and reiterated... More